Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
FSCN1 - beta-TrCP inhibition and androgen ablation effects on prostate cancer cell line LAPC4
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
beta-TrCP inhibition and androgen ablation effects on prostate cancer cell line LAPC4
GEO DataSets Profile neighbors
AMELX - beta-TrCP inhibition and androgen ablation effects on prostate cancer cell line LAPC4
S100A5 - beta-TrCP inhibition and androgen ablation effects on prostate cancer cell line LAPC4
DST - beta-TrCP inhibition and androgen ablation effects on prostate cancer cell line LAPC4
SCD - beta-TrCP inhibition and androgen ablation effects on prostate cancer cell line LAPC4
KLK8 - beta-TrCP inhibition and androgen ablation effects on prostate cancer cell line LAPC4
HIF3A - beta-TrCP inhibition and androgen ablation effects on prostate cancer cell line LAPC4
ADAM18 - beta-TrCP inhibition and androgen ablation effects on prostate cancer cell line LAPC4
IRF4 - beta-TrCP inhibition and androgen ablation effects on prostate cancer cell line LAPC4
IDH3B - beta-TrCP inhibition and androgen ablation effects on prostate cancer cell line LAPC4
RPS17 - beta-TrCP inhibition and androgen ablation effects on prostate cancer cell line LAPC4
CTSC - beta-TrCP inhibition and androgen ablation effects on prostate cancer cell line LAPC4
ELAC1 - beta-TrCP inhibition and androgen ablation effects on prostate cancer cell line LAPC4
SMARCA4 - beta-TrCP inhibition and androgen ablation effects on prostate cancer cell line LAPC4
SPATS2L - beta-TrCP inhibition and androgen ablation effects on prostate cancer cell line LAPC4
CYR61 - beta-TrCP inhibition and androgen ablation effects on prostate cancer cell line LAPC4
NOD2 - beta-TrCP inhibition and androgen ablation effects on prostate cancer cell line LAPC4
LGALS2 - beta-TrCP inhibition and androgen ablation effects on prostate cancer cell line LAPC4
RAPGEF2 - beta-TrCP inhibition and androgen ablation effects on prostate cancer cell line LAPC4
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on